| CTRI Number |
CTRI/2025/09/095479 [Registered on: 30/09/2025] Trial Registered Prospectively |
| Last Modified On: |
29/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy
Physiotherapy (Not Including YOGA) |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Importance of Homoeopathy in management of Gout |
|
Scientific Title of Study
|
A clinical study to assess the predominancy of sycotic miasm in case of gout with effectiveness of anti-sycotic homoeopathic medicine |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Purvang Gajjar |
| Designation |
MD Scholar |
| Affiliation |
Rajkot Homoeopathic Medical College |
| Address |
Room no 104, Department of Organon of Medicine, Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
Room no 104, Department of Organon of Medicine, Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
Amreli
GUJARAT
364515
India |
| Phone |
6354252539 |
| Fax |
|
| Email |
purvang.h.gajjar@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
Dr Bibhu Prasad Panda |
| Designation |
HOD / Professor |
| Affiliation |
Rajkot Homoeopathic Medical College |
| Address |
Room no 104, Department of Organon of Medicine, Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
Room no 104, Department of Organon of Medicine, Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
Rajkot
GUJARAT
360002
India |
| Phone |
9687657405 |
| Fax |
|
| Email |
bprasadpanda@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
Dr Bibhu Prasad Panda |
| Designation |
HOD / Professor |
| Affiliation |
Rajkot Homoeopathic Medical College |
| Address |
Kevdavadi, Bhaktinagar, Rajkot
Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
GUJARAT
360002
India |
| Phone |
9687657405 |
| Fax |
|
| Email |
bprasadpanda@gmail.com |
|
|
Source of Monetary or Material Support
|
| Rajkot Homoeopathic Medical College |
|
|
Primary Sponsor
|
| Name |
Rajkot Homoeopathic Medical College |
| Address |
Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
| Name |
Address |
| Sainath Homoeopathic Hospital |
Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot |
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Purvang Gajjar |
Sainath Homoeopathic Hospital |
Room no 104, Department of Organon of Medicine, Behind Jaynath Complex, Makkam Chowk, Gondal Road, Rajkot
Rajkot
GUJARAT |
6354252539
purvang.h.gajjar@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee for Human Research - Rajkot Homoeopathic Medical College (RHMC), Parul University, Gujarat |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M109||Gout, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Individualized Homoeopathic Medicine |
Individualized Homoeopathic Medicine will be administered in 30, 200, 1m potencies at the interval of 7 days to 15 days |
| Comparator Agent |
Placebo |
Placebo will be administered at the interval of 7 days to 15 days |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
NIL |
|
| ExclusionCriteria |
| Details |
Presence of serious comorbidities (e.g., malignancy, uncontrolled diabetes, severe cardiac disease) |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To evaluate the predominance of the sycotic miasm in cases of gout |
Within 8 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="40"
Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
13/10/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
13/10/2025 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1"
Months="0"
Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol
Response - Clinical Study Report
- Who will be able to view these files?
Response - Researchers who provide a methodologically sound proposal.
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [purvang.h.gajjar@gmail.com].
- For how long will this data be available start date provided 01-10-2025 and end date provided 31-12-2026?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Homoeopathic approach in curing a disease is not only treating the presenting symptoms
of disease but is to cure person in disease as a whole.
Constitutional approach is must to reach the Similimum. Homoeopathic physicians select
remedies on Totality
of Symptoms, not only based
on physical symptoms, but also lifestyle, character, mental and emotional
state, stress levels, diet, family history and other general factors in order to
prescribe best remedy. Homoeopathy considers health as a state indicating
harmonious functioning of life force. Disease is a deviation
from health, which
develops when vital force is unable to overcome obstruction to its smooth functioning.
Miasms are the fundamental cause of every
disease so as in case of hyperuricaemia and gout. Miasm disposes
the body towards a certain
diathesis. Patient develops
hyperuricaemia due to their uric acid or lithic diathesis. These patients develop gout and other rheumatic pains because they have tendency to build up high level of uric acid in their bodies.
In case of uric acid
or lithic diathesis predominant miasm is Sycosis but psoric and syphilitic
miasm also plays a significant role in development and complications of gout.
Individualisation is
must in curing a disease. No two gout patient are treated with same treatment
but are treated as distinct individuals, each uniquely influenced by different
factors with each patient being prescribed a remedy that matches their symptom.
Instead of constitutional approach some important medicines are very useful in
preventing the gout and its clinical symptoms |